← All diseases

Disease Atlas / Disease detail

Pneumocystis infection

This is educational material that briefly summarizes the definition, risk factors, symptoms, diagnosis, management, and evidence interpretation of Pneumocystis infection and PCP.

Pneumocystis infectious disease · Pneumocystis infection · infections, Pneumocystis

MONDO:0005923Public QA completeSource-bound · 4

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · fce8224cecfe

Disease category
Pneumocystis infection is an infection caused by the fungus Pneumocystis jirovecii, and its representative clinical form is pneumonia (PCP).
Core mechanism
Pneumocystis jirovecii can be transmitted between humans through the air, and even asymptomatic individuals can be involved in transmission.
Main causes · related factors
When immune defenses are weakened, Pneumocystis can proliferate in the lungs and interfere with gas exchange in the alveoli, potentially causing hypoxic respiratory failure.
Representative patterns
Representative symptoms of PCP include fever, cough, dyspnea, chest pain, chills, and fatigue.
Individual differences
HIV, autoimmune diseases, cancer, chronic lung disease, organ/bone marrow transplantation, and immunosuppressive treatments such as chemotherapy or steroids can increase the risk.
Diagnosis
Symptoms can progress over several days to weeks, and severe PCP can be life-threatening.
Management
Diagnosis centers on testing respiratory specimens obtained via sputum, bronchoalveolar lavage, or lung biopsy for Pneumocystis.
Treatment/Research Status
Do not conclude pneumonia solely based on the detection of the organism in a specimen; symptoms, imaging findings, oxygenation status, and immune status must be interpreted together.
Read Evidence
Management is based on early evaluation and antimicrobial therapy, and severe cases may require hospitalization and respiratory and oxygenation support.
Key Precautions
MedlinePlus explains that PCP treatment uses oral or intravenous antimicrobials, with a treatment duration of about 3 weeks.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a Glance

Pneumocystis infection is an infection caused by the fungus Pneumocystis jirovecii, and its representative clinical form is pneumonia (PCP).

Representative symptoms of PCP include fever, cough, dyspnea, chest pain, chills, and fatigue.

How the disease works

Pneumocystis jirovecii can be transmitted between humans through the air, and even asymptomatic individuals can be involved in transmission.

When immune defenses are weakened, Pneumocystis can proliferate in the lungs and interfere with gas exchange in the alveoli, potentially causing hypoxic respiratory failure.

Variations in presentation among individuals

HIV, autoimmune diseases, cancer, chronic lung disease, organ/bone marrow transplantation, and immunosuppressive treatments such as chemotherapy or steroids can increase the risk.

The broad framework of diagnosis and management

Symptoms can progress over several days to weeks, and severe PCP can be life-threatening.

Diagnosis centers on testing respiratory specimens obtained via sputum, bronchoalveolar lavage, or lung biopsy for Pneumocystis.

Current status of treatment

Do not conclude pneumonia solely based on the detection of the organism in a specimen; symptoms, imaging findings, oxygenation status, and immune status must be interpreted together.

Management is based on early evaluation and antimicrobial therapy, and severe cases may require hospitalization and respiratory and oxygenation support.

MedlinePlus explains that PCP treatment uses oral or intravenous antimicrobials, with a treatment duration of about 3 weeks.

How to read clinical trials

The registered NCT07004127 study is an observational study targeting patients over 75 years of age; even if marked as completed, there are no results, so it does not demonstrate treatment efficacy or standard of care.

Points to verify during clinical consultations

In clinical practice, it is important to verify immunosuppressive diseases and medications, symptom onset and rate of worsening, dyspnea and oxygen saturation, specimen collection, and treatment plans.

Medical Guidance

This material is for educational purposes and is not intended as a guide for individual diagnosis or treatment. Please consult a medical professional if symptoms occur or worsen.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.